Ausgewählte aktuelle Publikationen von Prof. Dr. rer. nat Boris Schmidt

  • B. Schmidt, D. Meid, D. Kieser, Safe and Fast Tetrazole Formation in Ionic Liquids, Tetrahedron 2007, 63, 492-
    496. http://dx.doi.org/10.1016/j.tet.2006.10.057 (IF 2.64)
  • A. Zall, D. Bensinger, B. Schmidt, Oxidative homologation of aldehydes to α-ketoaldehydes by iodoform, IBX
    and dimethylsulfoxide. Eur. J. Org. Chem. 2012 accepted 22.12.2011. http://dx.doi.org/10.1002/ejoc.201101835
  • L. Danielyan*, A. Lourhmati, S.Verleysdonk, B. Proksch, S. Umbreen, B. Schmidt, C.H. Gleiter. Angiotensin
    receptor type 1 blockade in astrocytes decreases hypoxia-induced cytotoxicity and inflammation. Neurochemical
    Research 2007, 9, 1489-1498. http://dx.doi.org/10.1007/s11064-007-9337-6 (IF 2.14)
  • D. Werner, U. Werner, A.Meybaum; B. Schmidt, S.Umbreen, A. Grosch; H. G. Lestin; B. Graf; O.Zolk; M.F.
    Fromm. Determinants of steady-state torasemide pharmacokinetics: Impact of gender, pharmacogenetic factors
    and angiotensin II receptor blockers. Clinical Pharmacokinetics 2008, 47(5), 323-32. (IF 4.11)
  • F. Lo Monte, T. Kramer, J. Gu, U. Anumala, L. Marinelli, V. La Pietra, E. Novellino, B. Franco, D.
    Demedts, F. Van Leuven, A. Fuertes, J. Dominguez, B. Plotkin, H. Eldar-Finkelman, B. Schmidt.
    Identification of Glycogen Synthase Kinase-3 Inhibitors with a Selective Sting for Glycogen Synthase
    Kinase-3α. J. Medicinal Chemistry 2012, 55 (9), 4407–4424. DOI 10.1021/jm300309a
  • F. Lo Monte, T. Kramer, J. Gu, M. Brodrecht, J. Pilakowski, Ana Fuertes, J. M. Dominguez, B. Plotkin, H. Eldar-
    Finkelman, B. Schmidt, Structure-based optimization of oxadiazole-based GSK-3 inhibitors. European J. Med.
    Chem. 2012, accepted 3.6.2012. http://dx.doi.org/10.1016/j.ejmech.2012.06.006
  • A. Boländer, D. Kieser, C. Voss, S. Bauer, C. Schön, S. Burgold, T. Bittner, J. Hölzer, R. Heyny-von
    Haußen, G. Mall, V. Goetschy, C. Czech, H. Knust, R. Berger, J. Herms, I. Hilger, B. Schmidt.
    Bis(arylvinyl)pyrazines, -pyrimidines and -pyridazines as Imaging Agents for Tau Fibrils and β-Amyloid
    Plaques in Alzheimer’s Disease Models J. Medicinal Chemistry 2012, accepted:
  • Elucidation of α-Keto-Aldehyde Binding Mechanism Reveals a Novel Lead Structure Motif for Proteasome
    Inhibition. M. Poynor, N. Gallastegui, M. Stein, B. Schmidt, P. M. Kloetzel, R. Huber, M. Groll.
    Angew. Chemie 2011, 123 (2), 563-566. http://onlinelibrary.wiley.com/doi/10.1002/ange.201005488/abstract
  • V. Lo Sardo, C. Zuccato, G. Gaudenzi, B. Vitali, C. Ramos, M. Tartari, M.A. Myre, J.A. Walker, A. Postocchi, L.
    Conti, M. Valenza, B. Drung, B. Schmidt, J. Gusella, S. Zeitlin, F. Cotelli, E. Cattaneo. An evolutionary recent
    neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin.
    Nature Neuroscience 2012, 15, 713–721. (IF 14.19), dx.doi.org/10.1038/nn.3080
  • T. Kramer, F. Lo Monte, S. Göring, G.M. Okala Amombo, B. Schmidt. ACS Chemical Neuroscience 2012, 3(3),
    151-160, Small molecule kinase inhibitors for LRRK2 and their application to Parkinson´s disease models
    http://pubs.acs.org/doi/abs/10.1021/cn200117j
  • T. Kramer, Boris Schmidt, F. Lo Monte, International Journal of Alzheimer's Disease 2012, Small-molecule
    inhibitors of GSK-3 - Structural insights and their application to Alzheimer´s disease models, accepted 31.1.2012.
    http://www.hindawi.com/journals/ijad/aip/381029/
 

Newsletter

Hier können Sie unseren kostenlosen Newsletter der Hans und Ilse Breuer-Stiftung bestellen und sich regelmäßig über die Entwicklungen sowie aktuelle Preisträger der Stiftung informieren.